Cargando…

A narrative review of the importance of pharmacokinetics and drug–drug interactions of preventive therapies in migraine management

OBJECTIVE: To review the pharmacokinetics of major classes of migraine preventives and the clinical implications of drug–drug interactions (DDIs) with the use of these therapies in migraine management. BACKGROUND: Preventive treatments for migraine are recommended for a large proportion of patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Joshi, Shivang, Tepper, Stewart J., Lucas, Sylvia, Rasmussen, Soeren, Nelson, Rob
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361687/ https://www.ncbi.nlm.nih.gov/pubmed/34214182 http://dx.doi.org/10.1111/head.14135

Ejemplares similares

Multimodal Migraine Management and the Pursuit of Migraine Freedom: A Narrative Review
por: Blumenfeld, Andrew M., et al.
Publicado: (2023)

Role of Calcitonin Gene-Related Peptide on the Gastrointestinal Symptoms of Migraine—Clinical Considerations: A Narrative Review
por: Ailani, Jessica, et al.
Publicado: (2022)

Interaction of Hydroxychloroquine with Pharmacokinetically Important Drug Transporters
por: Weiss, Johanna, et al.
Publicado: (2020)

The Issue of Pharmacokinetic-Driven Drug-Drug Interactions of Antibiotics: A Narrative Review
por: Cattaneo, Dario, et al.
Publicado: (2022)

Pharmacokinetic Drug–Drug Interactions and Herb–Drug Interactions
por: Choi, Min-Koo, et al.
Publicado: (2021)

Pharmacokinetic drug-drug interaction and their implication in clinical management
por: Palleria, Caterina, et al.
Publicado: (2013)

Pharmacokinetics and safety of ubrogepant when coadministered with calcitonin gene‒related peptide‐targeted monoclonal antibody migraine preventives in participants with migraine: A randomized phase 1b drug–drug interaction study
por: Jakate, Abhijeet, et al.
Publicado: (2021)

Importance of Drug Pharmacokinetics at the Site of Action
por: Rizk, ML, et al.
Publicado: (2017)

Preventive treatment in migraine and the new US guidelines
por: Estemalik, E, et al.
Publicado: (2013)

Pharmacokinetics, Pharmacodynamics and Drug–Drug Interactions of New Anti-Migraine Drugs—Lasmiditan, Gepants, and Calcitonin-Gene-Related Peptide (CGRP) Receptor Monoclonal Antibodies
por: Szkutnik-Fiedler, Danuta
Publicado: (2020)

EHMTI-0022. Pharmacokinetic variability of drugs used for prophylactic treatment in migraine
por: Pavbro, P, et al.
Publicado: (2014)

Preventive Agents for Migraine: Focus on the Antiepileptic Drugs
por: Shahien, R., et al.
Publicado: (2012)

Major Neurologic Adverse Drug Reactions, Potential Drug–Drug Interactions and Pharmacokinetic Aspects of Drugs Used in COVID-19 Patients with Stroke: A Narrative Review
por: Ghasemiyeh, Parisa, et al.
Publicado: (2020)

Pharmacokinetics of sumatriptan in non-respondent and in adverse drug reaction reporting migraine patients
por: Sternieri, E., et al.
Publicado: (2005)

Optimising migraine treatment: from drug-drug interactions to personalized medicine
por: Pomes, Leda Marina, et al.
Publicado: (2019)

Managing clinically important drug interactions
por: Hansten, Philip D.
Publicado: (2003)

Real world preventative drug management of migraine among Spanish neurologists
por: García-Azorin, D., et al.
Publicado: (2019)

Prophylaxis of migraine: general principles and patient acceptance
por: D’Amico, Domenico, et al.
Publicado: (2008)

Pharmacokinetic Drug Interaction Studies with Enzalutamide
por: Gibbons, Jacqueline A., et al.
Publicado: (2015)

Vortioxetine: Clinical Pharmacokinetics and Drug Interactions
por: Chen, Grace, et al.
Publicado: (2017)

Strategies of care for acute treatment of migraine
por: Tepper, Stewart J., et al.
Publicado: (2002)

Extraction of Pharmacokinetic Evidence of Drug–Drug Interactions from the Literature
por: Kolchinsky, Artemy, et al.
Publicado: (2015)

Pharmacokinetic and Drug–Drug Interaction Profiles of the Combination of Tezacaftor/Ivacaftor
por: Garg, Varun, et al.
Publicado: (2019)

Drug–Drug Interactions Of Amiodarone And Quinidine On The Pharmacokinetics Of Eliglustat In Rats
por: Wang, Qiong, et al.
Publicado: (2019)

The pharmacokinetics and drug-drug interactions of ivermectin in Aedes aegypti mosquitoes
por: Duthaler, Urs, et al.
Publicado: (2021)

Pharmacokinetic and Pharmacodynamic Drug–Drug Interactions: Research Methods and Applications
por: Sun, Lei, et al.
Publicado: (2023)

Enantiospecific pharmacokinetics and drug–drug interactions of primaquine and blood-stage antimalarial drugs
por: Chairat, Kalayanee, et al.
Publicado: (2018)

Vascular safety of erenumab for migraine prevention
por: Kudrow, David, et al.
Publicado: (2020)

Drug-drug Interactions: The Importance of Medication Reconciliation
por: Makiani, Mahin Jamshidi, et al.
Publicado: (2017)

Timing and durability of response to erenumab in patients with chronic migraine
por: Tepper, Stewart J., et al.
Publicado: (2021)

Erenumab prevents the occurrence of migraine attacks and not just migraine days: Post-hoc analyses of a phase III study
por: Diener, Hans-Christoph, et al.
Publicado: (2021)

Pharmacokinetics and Drug‐Drug Interactions of Isoniazid and Efavirenz in Pregnant Women Living With HIV in High TB Incidence Settings: Importance of Genotyping
por: Gausi, Kamunkhwala, et al.
Publicado: (2020)

The Influence of Pharmacogenetics on the Clinical Relevance of Pharmacokinetic Drug–Drug Interactions: Drug–Gene, Drug–Gene–Gene and Drug–Drug–Gene Interactions
por: Hahn, Martina, et al.
Publicado: (2021)

Physiologically‐Based Pharmacokinetic Modeling to Support the Clinical Management of Drug–Drug Interactions With Bictegravir
por: Stader, Felix, et al.
Publicado: (2021)

New drugs for migraine
por: Stovner, Lars Jacob, et al.
Publicado: (2009)

A review of significant pharmacokinetic drug interactions with antidepressants and their management
por: Hoffelt, Charity, et al.
Publicado: (2016)

Comparing the applications of machine learning, PBPK, and population pharmacokinetic models in pharmacokinetic drug–drug interaction prediction
por: Gill, Jaidip, et al.
Publicado: (2022)

Potential Pharmacokinetic Drug-Drug Interactions between Cannabinoids and Drugs Used for Chronic Pain
por: Vázquez, Marta, et al.
Publicado: (2020)

Pharmacokinetic Drug-Drug Interaction and Responsible Mechanism between Memantine and Cimetidine
por: Choi, Young A., et al.
Publicado: (2018)

Pharmacokinetics and Drug–Drug Interactions of Long-Acting Intramuscular Cabotegravir and Rilpivirine
por: Hodge, Daryl, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j077ba6olkhnnpsdt6flidj2ig